CS logo
small CS logo
Turku Uni Central Hospital; Oncology Clinics

Turku, Finland
Hospital in Turku
Kiinamyllynkatu 4-8, 20521 Turku
900 Beds

About Turku Uni Central Hospital; Oncology Clinics


Turku University Hospital is a hospital in Turku, Finland.
There are 900 beds in Turku Uni Central Hospital; Oncology Clinics.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
10
Genentech, Inc.
1
Total Rows: 2

Clinical Trials at Turku Uni Central Hospital; Oncology Clinics


During the past decade, Turku Uni Central Hospital; Oncology Clinics conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 6 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1111001100001100111111111111Started TrialsCompleted Trails201520162017201820192020202100.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
2003-04-18
2011-04-21
Completed
1,886
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer
2008-02-12
2018-11-23
Completed
808
A Study of Vemurafenib in Participants With Metastatic Melanoma
2011-03-01
2016-02-24
Completed
3,219
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
2012-06-01
2019-09-20
Completed
1,436
A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma
2012-08-24
2016-09-16
Completed
572
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment
2012-11-27
2020-07-31
Completed
2,185
A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer
2013-06-10
2019-12-31
Completed
780
A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy
2015-04-09
2021-06-29
Terminated
631

Rows per page:

1–11 of 11

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Turku Uni Central Hospital; Oncology Clinics" #1 collaborator was "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 10Hoffmann-La Roche: 10Genentech, Inc.: 1Genentech, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsHoffmann-La Roche: 1Hoffmann-La Roche: 1

Clinical Trials Conditions at Turku Uni Central Hospital; Oncology Clinics


According to Clinical.Site data, the most researched conditions in "Turku Uni Central Hospital; Oncology Clinics" are "Breast Cancer" (2 trials), "Breast Neoplasms" (1 trials), "Colorectal Cancer" (1 trials), "Gastric Cancer" (1 trials) and "Lymphoma, Large B-Cell, Diffuse" (1 trials). Many other conditions were trialed in "Turku Uni Central Hospital; Oncology Clinics" in a lesser frequency.

Clinical Trials Intervention Types at Turku Uni Central Hospital; Oncology Clinics


Most popular intervention types in "Turku Uni Central Hospital; Oncology Clinics" are "Drug" (11 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Atezolizumab" (3 trials), "Capecitabine" (3 trials), "Pertuzumab" (3 trials) and "Trastuzumab" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Turku Uni Central Hospital; Oncology Clinics


The vast majority of trials in "Turku Uni Central Hospital; Oncology Clinics" are 10 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Turku Uni Central Hospital; Oncology Clinics


Currently, there are NaN active trials in "Turku Uni Central Hospital; Oncology Clinics". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Turku Uni Central Hospital; Oncology Clinics, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Turku Uni Central Hospital; Oncology Clinics, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 11Phase 3: 11

Created with Highcharts 11.1.0Trials StatusCompleted: 7Completed: 7Recruiting: 2Recruiting: 2Active, not recruiting: 1Active, not recruiting: 1Terminated: 1Terminated: 1